Results for tag: "Imprida"

The Imprida market is a segment of the cardiovascular drugs market that focuses on treatments for heart failure. It includes drugs that are used to reduce the symptoms of heart failure, such as shortness of breath, fatigue, and swelling in the legs and feet. These drugs can also help to improve the quality of life for those with heart failure. The Imprida market includes drugs that are used to reduce the risk of hospitalization and death due to heart failure. These drugs can also help to reduce the risk of stroke and other cardiovascular events. The Imprida market is made up of a variety of companies, including Novartis, Amgen, and AstraZeneca. These companies are focused on developing and marketing drugs that can help to improve the quality of life for those with heart failure. Other companies in the Imprida market include Merck, Pfizer, and Sanofi. These companies are focused on developing and marketing drugs that can help to reduce the risk of hospitalization and death due to heart failure. Show Less Read more